Literature DB >> 20439390

Processing speed deficits in schizophrenia: reexamining the evidence.

Emma E M Knowles1, Anthony S David, Abraham Reichenberg.   

Abstract

OBJECTIVE: A recent meta-analysis identified processing speed inefficiency as the largest single cognitive impairment in schizophrenia. However, the effect of potential moderator variables, such as medication status and severity of illness, remained unclear. The authors present an extended meta-analysis of processing speed and other specific cognitive functions in schizophrenia and examine the role of potential moderator variables.
METHOD: In addition to the studies identified in the original analysis, subsequently published articles were identified via systematic searches of MEDLINE and PsycINFO for the period from May 2006 to January 2009. The authors extracted data for potential moderator variables, including publication year; severity of illness; chlorpromazine equivalent daily dose; and mean IQ, mean age, and sample size for each study. Effect sizes were calculated for all measures, and meta-influence and homogeneity analyses were conducted.
RESULTS: Eleven studies were added to the original analysis, increasing the schizophrenia sample size from 1,915 to 4,135. The largest effect size was for coding tasks (g=-1.50), followed by category fluency (g=-1.31). However, for coding tasks, variation in effect size magnitude attributable to heterogeneity was substantial. Metaregression analyses indicated that three moderator variables were related to coding task effect size: publication year, IQ difference from comparison subjects, and chlorpromazine equivalent daily dose. There was a difference of 0.8 effect size units between studies with low compared with high chlorpromazine equivalent daily dose. No significant relationships were found between any moderators and the other cognitive tasks included in the meta-analysis.
CONCLUSIONS: The processing speed impairment in schizophrenia is substantially affected by several moderating factors, in particular antipsychotic medication dosage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439390     DOI: 10.1176/appi.ajp.2010.09070937

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  85 in total

1.  Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia.

Authors:  O Puig; R Penadés; I Baeza; V Sánchez-Gistau; E De la Serna; L Fonrodona; S Andrés-Perpiñá; M Bernardo; J Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-22       Impact factor: 4.785

2.  Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.

Authors:  Hiroyoshi Takeuchi; Takefumi Suzuki; Gary Remington; Robert R Bies; Takayuki Abe; Ariel Graff-Guerrero; Koichiro Watanabe; Masaru Mimura; Hiroyuki Uchida
Journal:  Schizophr Bull       Date:  2013-07-01       Impact factor: 9.306

3.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

4.  Specificity of executive functioning and processing speed problems in common psychopathology.

Authors:  Joel T Nigg; Jennifer M Jester; Gillian M Stavro; Ka I Ip; Leon I Puttler; Robert A Zucker
Journal:  Neuropsychology       Date:  2017-01-16       Impact factor: 3.295

5.  Potassium channel gene associations with joint processing speed and white matter impairments in schizophrenia.

Authors:  H A Bruce; P Kochunov; S A Paciga; C L Hyde; X Chen; Z Xie; B Zhang; H S Xi; P O'Donnell; C Whelan; C R Schubert; A Bellon; S A Ament; D K Shukla; X Du; L M Rowland; H O'Neill; L E Hong
Journal:  Genes Brain Behav       Date:  2017-03-13       Impact factor: 3.449

6.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

7.  The Processing-Speed Impairment in Psychosis Is More Than Just Accelerated Aging.

Authors:  Samuel R Mathias; Emma E M Knowles; Jennifer Barrett; Olivia Leach; Sebastiano Buccheri; Tamara Beetham; John Blangero; Russell A Poldrack; David C Glahn
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

8.  Increasing stimulus duration can normalize late-positive event related potentials in people with schizophrenia: Possible implications for understanding cognitive deficits.

Authors:  Bruce E Wexler; Satoru Ikezawa; Silvia Corbera
Journal:  Schizophr Res       Date:  2014-08-03       Impact factor: 4.939

9.  Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.

Authors:  Joshua Chiappelli; Ana Pocivavsek; Katie L Nugent; Francesca M Notarangelo; Peter Kochunov; Laura M Rowland; Robert Schwarcz; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

10.  Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study.

Authors:  S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.